| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.9 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |